Endonovo Therapeutics, Inc.

Endonovo Therapeutics, Inc.

ENDV
Endonovo Therapeutics, Inc.US flagOther OTC
0.00
USD
- -
- -
31,875.00Market Cap

Endonovo Therapeutics, Inc. (ENDV) Stock Split History

Learn about Endonovo Therapeutics, Inc.'s most recent 1-for-1000 basis stock split on December 20, 2019. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Endonovo Therapeutics, Inc.'s most recent stock split

Split Date: 2019-12-20
Split Ratio: 1:1000
Price Before Split: $0.00
Price After Split: $0.00

Developer API

Get ENDV split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/ENDV

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1000.00 times fewer shares (a 1:1000 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Endonovo Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2019-12-201:1000Yes$0.00$0.00
2014-05-151:100Yes$0.00$0.00

About Endonovo Therapeutics, Inc.

Company overview and industry information

Endonovo Therapeutics, Inc. (ENDV) operates in the Biotechnology industry. The recent 1-for-1000 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Endonovo Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.